United States patent law

Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, November 9, 2023
FDA, Research, PKU, Patent, AbbVie, PAL, International Conference on Nuclear Disarmament, Oslo, 2008, Homocystinuria, Treatment, University, Conference, Progress, Phenylketonuria, Partnership, Head, United States patent law, Methionine, Lead, Pittsburgh, Investment, Inflammatory bowel disease, Nature Metabolism, Nursing, Pharmaceutical industry, Cryptocurrency, Vitro

CAMBRIDGE, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today reported financial results for the third quarter ended September 30, 2023, and provided a corporate update.

Key Points: 
  • Publication of Synpheny-1 Phase 2 study results for the PKU program in the journal Nature Metabolism.
  • Presentation of Synpheny-1 Phase 2 study results by lead investigator Dr. Jerry Vockley of the University of Pittsburgh at the 37th E.S.PKU Conference 2023.
  • Revenue for the three months ended September 30, 2023 was $0.4 million compared to $0.7 million for the corresponding period in 2022.
  • General and administrative expenses were $3.4 million for the three months ended September 30, 2023, compared to $4.4 million for the corresponding period in 2022.

Systech Launches a Breakthrough in Product Security

Retrieved on: 
Wednesday, November 8, 2023
Cloud, Smartphone, QR, Skin care, Congress, Root cause analysis, Artificial intelligence, Risk, Digital Production Partnership, United States patent law, Systech Corporation, Patent, Markem-Imaje, Retail, Security printing, Video game

UniSecure provides unique product identification, traceability and product verification via smartphone across the supply chain in the pharmaceutical, nutraceutical, medical products, skin care and other markets.

Key Points: 
  • UniSecure provides unique product identification, traceability and product verification via smartphone across the supply chain in the pharmaceutical, nutraceutical, medical products, skin care and other markets.
  • Currently, anti-counterfeiting technologies are invasive to the product or its packaging and have additional overhead.
  • "Delivering product and consumer protection through existing barcodes and QR codes has never been easier," said Sreedhar Patnala, Vice President, Digital Products.
  • Systech will showcase the next generation of UniSecure at the upcoming 2023 AIPIA World Congress, which will be held from November 14-15 at the Beurs van Berlage in Amsterdam, Netherlands.

Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office

Retrieved on: 
Wednesday, November 8, 2023
Patent, ZEUS robotic surgical system, United States patent law, 3D printing, Fine chemical

BRAINTREE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic system, today announced it had been granted a registered trademark from the US Patent and Trademark Office.

Key Points: 
  • BRAINTREE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic system, today announced it had been granted a registered trademark from the US Patent and Trademark Office.
  • The trademark “One & Done®” was given to the feature of the LIBERTY Robotic Surgical System which is being developed to integrate guidewires, microcatheters and other instruments required for complete endovascular procedures using the device.
  • With this trademark, the Company continues to expand its proprietary assets, including numerous approved and pending patents all over the world, and differentiate its product’s capabilities.

Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023

Retrieved on: 
Wednesday, November 8, 2023
Biotechnology, Pharmaceutical, Health, Adrenoleukodystrophy, Patient, Serono, ALD, Plasma, AMN, Patent, Biomarker, Sumitomo Pharma, Diabetes, Merck, SGLT2, Jaguar 3.4 Litre, EPO, Pharmacokinetics, Male, DPP4, Disease, Prescription, Marshal of France, Pioglitazone, European Patent Office, EUR, United States patent law, Merck Serono, VLCFA, Safety, European Patent Convention, JPY, Estonia, Kidney, POC, Pharmaceutical industry, Imeglimin

Sumitomo Pharma has worked diligently to increase the production and secure inventory capacity to meet this increasing demand.

Key Points: 
  • Sumitomo Pharma has worked diligently to increase the production and secure inventory capacity to meet this increasing demand.
  • For the Sumitomo Pharma FY 2023, as a conservative assumption in line with Sumitomo Pharma’s forecast, Poxel expects to receive 8% royalties on TWYMEEG net sales.
  • On July 5th, Poxel was chosen as the winner of the 2023 edition of the I-nov contest for its program in ALD.
  • Next Financial Press Release: Fourth Quarter 2023 Cash and Revenue update, on February 15, 2024

EXpressLO LLC Awarded U.S. Patent 11,808,679 for Cryo-EM Specimen Handling

Retrieved on: 
Tuesday, November 7, 2023
OH, Patent, Johns Hopkins, Microscopy and Microanalysis, Invention, MD, FIB, Research, Multimedia, APL, Bacteria, DOE, Applied Physics Laboratory, Microscopy, United States patent law, Microscope

LEHIGH ACRES, Fla., Nov. 7, 2023 /PRNewswire-PRWeb/ -- EXpressLO LLC was awarded U.S. Patent 11,808,679 from the U.S. Patent and Trademark Office describing highly innovative methods and apparatus for cryo-EXLO manipulation of biological and beam sensitive materials. EXpressLO LLC is the most comprehensive provider of focused ion beam (FIB) ex situ lift out (EXLO) specimen preparation solutions for transmission electron microscopy (EM) and other analytical techniques.

Key Points: 
  • EXpressLO LLC has been awarded U.S. Patent 11,808,679 from the USPTO for a unique cryogenic ex situ lift out specimen manipulation process for cryogenically prepared focused ion beam specimens.
  • LEHIGH ACRES, Fla., Nov. 7, 2023 /PRNewswire-PRWeb/ -- EXpressLO LLC was awarded U.S. Patent 11,808,679 from the U.S. Patent and Trademark Office describing highly innovative methods and apparatus for cryo-EXLO manipulation of biological and beam sensitive materials.
  • EXpressLO LLC is the most comprehensive provider of focused ion beam (FIB) ex situ lift out (EXLO) specimen preparation solutions for transmission electron microscopy (EM) and other analytical techniques.
  • The novel methods and apparatus described in this U.S. patent were invented by EXpressLO LLC founder and President, Dr. Lucille A. Giannuzzi.

EQS-News: EcoGraf Limited: September Quarterly Activities Report

Retrieved on: 
Tuesday, November 7, 2023
BAM, Lithium, ASX, CSR, Mining, EV, Patent, Corporate social responsibility, Opposition, Wenco International Mining Systems, Conference, Carbon, Gold, Commonwealth, EGR, Commissioner, AABC, News, Banyan, Delegate, Mineral, VinFast, United States patent law, Expo, Recycling, CO2, Nickel, Vingroup, Industries and Mines Commission of the Islamic Consultative Assembly, Security (finance), Electric battery, Cryptocurrency, Rare-earth element, Pharmaceutical industry

Vertically integrated battery anode materials developer EcoGraf Limited (“EcoGraf” or “the Company”) (ASX: EGR) is pleased to release its activities and cash flow reports for the three months ended 30 September 2023.

Key Points: 
  • Vertically integrated battery anode materials developer EcoGraf Limited (“EcoGraf” or “the Company”) (ASX: EGR) is pleased to release its activities and cash flow reports for the three months ended 30 September 2023.
  • VinES, together with VinFast - a global electric vehicle manufacturer, are both members of VinGroup, the largest private conglomerate in Vietnam.
  • Discussions are continuing with battery market participants on the establishment of commercial scale EcoGraf HFfree™ purification facilities in key global battery regions Europe, Asia and North America.
  • EcoGraf is building a vertically integrated battery anode materials business to produce high purity graphite products for the lithium-ion battery and advanced manufacturing markets.

Smartflash sues US Patent Office in ongoing Apple Racketeering Investigation

Retrieved on: 
Monday, October 30, 2023
Supreme court, FOIA, Racketeer Influenced and Corrupt Organizations Act, Illinois Freedom of Information Act, Freedom of Information Act, Organization, United States Patent and Trademark Office, Interview, United States patent law, United States v. Arthrex, Inc., RICO, PTAB, Patent, Apple

LONDON, Oct. 30, 2023 /PRNewswire/ -- Patrick Racz, founder, and inventor of Smartflash, has announced a lawsuit filed by Smartflash against the United States Patent and Trademark Office (USPTO) in connection with Smartflash's ongoing Civil RICO investigation into Apple.

Key Points: 
  • LONDON, Oct. 30, 2023 /PRNewswire/ -- Patrick Racz, founder, and inventor of Smartflash, has announced a lawsuit filed by Smartflash against the United States Patent and Trademark Office (USPTO) in connection with Smartflash's ongoing Civil RICO investigation into Apple.
  • In 2015, Racz won a resounding victory against Apple in court, with an initial jury award of $533 million for wilful infringement.
  • The key merits and findings of the case, namely that Apple infringed on the technology and induced others to infringe, remain undisturbed today.
  • For more information or to request an interview contact [email protected] or call Charles Carroll on +44 (0) 20 3176 2700.

Smartflash sues US Patent Office in ongoing Apple Racketeering Investigation

Retrieved on: 
Monday, October 30, 2023
Supreme court, FOIA, Racketeer Influenced and Corrupt Organizations Act, Illinois Freedom of Information Act, Freedom of Information Act, Organization, United States Patent and Trademark Office, Interview, United States patent law, United States v. Arthrex, Inc., RICO, PTAB, Patent, Apple

LONDON, Oct. 30, 2023 /PRNewswire/ -- Patrick Racz, founder, and inventor of Smartflash, has announced a lawsuit filed by Smartflash against the United States Patent and Trademark Office (USPTO) in connection with Smartflash's ongoing Civil RICO investigation into Apple.

Key Points: 
  • LONDON, Oct. 30, 2023 /PRNewswire/ -- Patrick Racz, founder, and inventor of Smartflash, has announced a lawsuit filed by Smartflash against the United States Patent and Trademark Office (USPTO) in connection with Smartflash's ongoing Civil RICO investigation into Apple.
  • In 2015, Racz won a resounding victory against Apple in court, with an initial jury award of $533 million for wilful infringement.
  • The key merits and findings of the case, namely that Apple infringed on the technology and induced others to infringe, remain undisturbed today.
  • For more information or to request an interview contact [email protected] or call Charles Carroll on +44 (0) 20 3176 2700.

Industrial 1U PCIe WatchDog Board from Amfeltec’s new PacketShark Family(TM) is in Production

Retrieved on: 
Tuesday, October 24, 2023
Internet of things, Temperature, US, Crash, Male, Watchdog timer, United States patent law, PCI Express, OS, Patent, Video game

STOUFFVILLE, Ontario, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amfeltec Corporation announced today the release of the smallest watchdog timer on the market to date: the first product of the new PacketShark Product Family(TM), the Industrial 1U x1 PCIe WatchDog Timer is in full production.

Key Points: 
  • STOUFFVILLE, Ontario, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amfeltec Corporation announced today the release of the smallest watchdog timer on the market to date: the first product of the new PacketShark Product Family(TM), the Industrial 1U x1 PCIe WatchDog Timer is in full production.
  • The PacketShark family’s purpose will be to monitor system operation, but also to facilitate recovery in case of operation-critical disruptions, such as a system crash or a power outage.”
    The 1U PCIe WatchDog Timer board can operate at industrial temperature rates (-40°C to +85°C).
  • The board can generate a system-reset signal to restart an embedded appliance in case of a system crash or overheat.
  • It is held securely inside a PCIe connector via Amfeltec’s PCIe Retainer (US Patent #7,850,475), eliminating the need for any bracket.

Trufacial™ Receives Patent for Innovative Dual-Function Plates Integrated Into Its Handheld Skin Rejuvenation System for Simultaneous Delivery of Specific Skin Perfecting Methods

Retrieved on: 
Wednesday, October 18, 2023
Other Retail, General Health, Health, Fashion, Luxury, Cosmetics, Retail, Other Health, Science, Attention, Patent, US, Absorption, Skin, Massage, Engineering, Love, United States patent law, Elasticity, Biomedical engineering, Beauty, 3D printing

This patent specifically covers Trufacial’s three dual-function plates that are integrated, one at a time, onto the front end, each for a specific skincare procedure.

Key Points: 
  • This patent specifically covers Trufacial’s three dual-function plates that are integrated, one at a time, onto the front end, each for a specific skincare procedure.
  • This novel utility patent optimizes the way Trufacial’s three treatment technologies are delivered to promote smoother, firmer and more toned skin.
  • According to Trufacial co-founder Dr. Mahmoud El-Sherif, “This patent recognizes the pioneering use of dual-function plates that can simultaneously apply two compatible skincare methods, maximizing the skin's response to specific treatments.
  • This patent pending method presents a simple and cost-effective approach for future expansion of the Trufacial system for multiple other applications.